Skip to main content
. 2016 Feb 29;6(2):e010469. doi: 10.1136/bmjopen-2015-010469

Table 3.

Classes of medications used in type 2 diabetes

Oral agents Injectable agents
Biguanides Short and rapid-acting human and animal insulins
Thiazolidinediones (‘glitazones’) Short and rapid-acting insulin analogues
Dual PPAR agonists Medium and long-acting human and animal insulins
Sulfonylureas Medium and long-acting insulin analogues
Meglitinides (‘glinides’) Mixed insulins
DPP-4 inhibitors (‘gliptins’) GLP-1 agonists
Alpha-glucosidase inhibitors Combined GLP-1 agonists and insulin
Amylin analogues Inhaled agents
SGLT 2 inhibitors (‘gliflozins’) Inhaled insulins
Combination oral preparations

DPP4, dipeptidyl peptidase 4; GLP-1, glucagon-like peptide 1; PPAR, peroxisome proliferator-activated receptor; SGLT-2, sodium-glucose co-transporter 2.